Skip to content

MiMedx Group MDXG Total Equity

Total Equity at other companies

IAR
Integra LifeSciencesIART
$1.04B-31.6%
Artivion logo
ArtivionAORT
$450.47M+53.1%
Solventum logo
SolventumSOLV
$4.97B+52.3%
Vericel logo
VericelVCEL
$356.23M+20.6%
Enovis logo
EnovisENOV
$1.48B-43.6%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$217.87M+5.9%

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's total equity?
MiMedx Group (MDXG) reported total equity of $242.94M in Q1 2026.
How has MiMedx Group's total equity changed year-over-year?
MiMedx Group's total equity increased by 19.8% year-over-year, from $202.78M to $242.94M.
What is the long-term trend for MiMedx Group's total equity?
Over 5 years (2020 to 2025), MiMedx Group's total equity has grown at a 343.2% compound annual growth rate (CAGR), from -$150K to $256.55M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.